Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) fell 31.3% during trading on Wednesday . The stock traded as low as C$0.14 and last traded at C$0.17. 1,643,425 shares were traded during trading, an increase of 198% from the average session volume of 550,572 shares. The stock had previously closed at C$0.24.
Voyageur Pharmaceuticals Stock Performance
The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The firm has a market cap of C$23.01 million, a PE ratio of -16.50 and a beta of 0.32. The firm’s 50 day moving average price is C$0.10 and its two-hundred day moving average price is C$0.07.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- Stock Dividend Cuts Happen Are You Ready?
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 Steel Stocks Soaring After Tariff Announcements
- ETF Screener: Uses and Step-by-Step Guide
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
